Bulevirtide

TERMINATED · · Chronic Hepatitis D Infection

Sponsor decision, no safety concerns.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.